338 filings
Page 11 of 17
8-K
c86tpb
3 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am
ARS
uwlgzxouvty6f0rwqcju
5 May 15
Annual report to shareholders
12:00am
8-K
sjw0 t3p9thq
30 Apr 15
Pacira Pharmaceuticals, Inc. Reports First Quarter EXPAREL Revenues of $56.0 Million and First Quarter 2015 Financial Results
12:00am
8-K
xclac uhj1bkh4noik
16 Apr 15
Other Events
12:00am
8-K
gtxy tq15wswoli6z2o
2 Mar 15
Pacira Receives Complete Response Letter from FDA for sNDA Seeking Approval of EXPAREL® Use in Nerve Block to Provide Postsurgical Analgesia
12:00am
8-K
dssggetvujtm5lxln
24 Feb 15
Pacira Pharmaceuticals, Inc. Reports 2014 Financial Results
12:00am
CT ORDER
8gyb 7rbao
19 Feb 15
Confidential treatment order
12:00am
8-K
1ptscs5ncfg
8 Jan 15
Pacira Pharmaceuticals, Inc. Reports Estimated Fourth Quarter Total Revenue of
12:00am
UPLOAD
a849t06321j0
3 Dec 14
Letter from SEC
12:00am
CT ORDER
ci0mf3ah5jk0olq
25 Nov 14
Confidential treatment order
12:00am
CORRESP
2z6v9s4fi83x t5cmfs4
7 Nov 14
Correspondence with SEC
12:00am
8-K
kiuyti gkr
30 Oct 14
Pacira Pharmaceuticals, Inc. Reports Third Quarter EXPAREL Revenue of
12:00am
UPLOAD
btt uw2dbco4tcfdo
27 Oct 14
Letter from SEC
12:00am
CT ORDER
b4p uxned6o
17 Sep 14
Confidential treatment order
12:00am
CT ORDER
mt4jlkwlilvhgnxjq
8 Sep 14
Confidential treatment order
12:00am
8-K
5j11gauqe4jo69cb3a4
27 Aug 14
Entry into a Material Definitive Agreement
12:00am